Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 2-(2-methylphenyl)-1H-indole-5-carboximidamide is an experimental small molecule compound belonging to the class of organic compounds known as indoles, specifically a 2-substituted phenylindole with a carboximidamide group at the 5-position. It has not been approved for any therapeutic use and is not currently in clinical development for any disease. The compound's structure suggests potential biological activity, as indole derivatives are often investigated for their roles in modulating neurotransmitter systems and may exhibit anti-inflammatory or anticancer properties; however, there is no direct evidence of its mechanism of action or specific pharmacological target[1][3][8]. No clinical trials have been reported for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-(2-methylphenyl)-1H-indole-5-carboximidamide.